Blue Bell Private Wealth Management LLC bought a new stake in shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF (BATS:XSEP – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 2,400 shares of the company’s stock, valued at approximately $86,000.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. PFS Partners LLC purchased a new stake in FT Vest U.S. Equity Enhance & Moderate Buffer ETF in the 3rd quarter worth approximately $63,000. Harbour Investments Inc. bought a new stake in FT Vest U.S. Equity Enhance & Moderate Buffer ETF in the fourth quarter valued at $85,000. Cape Investment Advisory Inc. boosted its holdings in FT Vest U.S. Equity Enhance & Moderate Buffer ETF by 60.9% in the third quarter. Cape Investment Advisory Inc. now owns 4,558 shares of the company’s stock valued at $155,000 after acquiring an additional 1,725 shares in the last quarter. Concourse Financial Group Securities Inc. purchased a new position in FT Vest U.S. Equity Enhance & Moderate Buffer ETF during the 3rd quarter valued at $208,000. Finally, Janney Montgomery Scott LLC bought a new position in FT Vest U.S. Equity Enhance & Moderate Buffer ETF in the 3rd quarter worth $224,000.
FT Vest U.S. Equity Enhance & Moderate Buffer ETF Stock Performance
Shares of BATS XSEP opened at $37.01 on Tuesday. The company’s 50-day moving average is $36.70 and its 200-day moving average is $35.57.
FT Vest U.S. Equity Enhance & Moderate Buffer ETF Company Profile
The FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF – September (XSEP) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to outperform the SPY ETF at about 2x positive price returns while aiming for specific buffered losses and capped gains over a specific holdings period.
Featured Stories
- Five stocks we like better than FT Vest U.S. Equity Enhance & Moderate Buffer ETF
- How to Use the MarketBeat Stock Screener
- BlackBerry Gains on IoT Growth, but Sours on Guidance Cut
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
Want to see what other hedge funds are holding XSEP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for FT Vest U.S. Equity Enhance & Moderate Buffer ETF (BATS:XSEP – Free Report).
Receive News & Ratings for FT Vest U.S. Equity Enhance & Moderate Buffer ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FT Vest U.S. Equity Enhance & Moderate Buffer ETF and related companies with MarketBeat.com's FREE daily email newsletter.